MDxHealth SA (MDXH) Misses Q4 EPS by 18c ; Offers Guidance

MDxHealth SA (NASDAQ: MDXH) reported Q4 EPS of ($0.39), $0.18 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $19.39 million versus the consensus estimate of $18.56 million.

GUIDANCE:

MDxHealth SA sees FY2024 revenue of $79-81 million, versus the consensus of $80.36 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Pfizer reaffirms 2026 guidance after CFO transition news
• Pfizer reafffirms 2026 guidance after CFO transition announcement